RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid...et conclut à une surmortalité toute causes confondues de 7%…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid...et conclut à une surmortalité toute causes confondues de 7%…
Quand la Cochrane étudie l' "efficacité" des vaccins anticovid...et conclut à une surmortalité toute causes confondues de 7% pour le groupe injecté avec seulement 6 mois de suivi et 2 doses ?... Comme en vie réelle quoi ? @decoder_l @NiusMarco 🔎🔎🔎 http
Sinon super efficace pour ne pas avoir un PCR+ On ferait un vaccin pour empêcher les gens de se marcher sur leurs lacets défaits , on éviterait plus de décès Du grand n'importe quoi https://t.co/LqpWheJNc7
Wirksamkeit und Sicherheit von COVID-19-Impfstoffen - Graña, C - 2022 | Cochrane Library https://t.co/VzEBGhfNML
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
@SteigstraHerman Dag Herman 👋, het louter vergelijken van landen is niet het enige onderzoek dat werd gedaan. Zoals deze review die de effectiviteit en veiligheid van de vaccinaties onderzocht. ⬇️ https://t.co/4CfcKlDfac
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
Efficacy and safety of COVID‐19 vaccines: Concerns about this Cochrane review of COVID-19 vaccines. https://t.co/vUUysR0bVN
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @sborg40: Important published response from Doshi et al about Pfizer/Moderna trials. https://t.co/BXyW6IcRtk
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
Important published response from Doshi et al about Pfizer/Moderna trials. https://t.co/BXyW6IcRtk
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
RT @jeffreyatucker: This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. htt…
This close analysis of a vaccine report is quite devastating, and a case study in how to mislead with study design. https://t.co/smeyhXB2dS
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
Efficacy and safety of COVID‐19 vaccines - Graña, C - 2022 | Cochrane Library https://t.co/TBN4uQGCZQ
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
RT @ScienceThorsten: Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of CO…
Yesterday, Peter Doshi and @JosephFraiman published their concerns about the Cochrane Review:Efficacy and safety of COVID‐19 vaccines (Dezember 2022). Thank you guys! It's worth a read and it's worth to spread! https://t.co/AaPELEdC3Y
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @CuendetV: 🔗 PDF de la lettre en 🇫🇷 https://t.co/2rTeBUQbSS 🔗 Source https://t.co/fIxaJR0sto 9/
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
Concerns about the Cochrane review of COVID-19 vaccines, published : 23 October 2023 by Peter Doshi https://t.co/WMufIxL2UE Le Français Jean-Daniel Lelievre de l'AP-HP parmi les auteurs. @tatiann69922625 @PinsolleT @AnneliseBocquet https://t.co/tLIYbIHUdn
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @CuendetV: 🔗 PDF de la lettre en 🇫🇷 https://t.co/2rTeBUQbSS 🔗 Source https://t.co/fIxaJR0sto 9/
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
RT @Dover63A: Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines aprè…
Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines après la dose 2 ? Soit un délai de carence de 4 à 6 semaines où après la dose 1 on n'est pas compté comme vacciné ? https://t.co/DQPkZ
Quand la Cochrane étudie l' "efficacité" des vaccins anticovid en ne comptant les cas positifs qu'à partir de 2 semaines après la dose 2 ? Soit un délai de carence de 6 à 8 semaine où après la dose 1 on n'est pas compté comme vacciné ? https://t.co/DQPkZC
RT @ResilientsTv: Critique de la revue Cochrane consacrée aux vaccins Covid par Peter,Doshi @JosephFraiman & co: https://t.co/JL7EORwIgl h…
RT @ResilientsTv: Critique de la revue Cochrane consacrée aux vaccins Covid par Peter,Doshi @JosephFraiman & co: https://t.co/JL7EORwIgl h…
Critique de la revue Cochrane consacrée aux vaccins Covid par Peter,Doshi @JosephFraiman & co: https://t.co/JL7EORwIgl https://t.co/tHcLj4Rzw9
🔗 PDF de la lettre en 🇫🇷 https://t.co/2rTeBUQbSS 🔗 Source https://t.co/fIxaJR0sto 9/
@teavangelize @susie5 @Debunk_the_Funk @CFA_Yin @Jessnimm @kastle1 @ACCP @MDaware They're not going to honestly evaluate the evidence. The giveaway on that was evading after their bad faith question on Prasad was addressed. https://t.co/NatzR15kLg https:/
@kastle1 @susie5 @Debunk_the_Funk @CFA_Yin @teavangelize @Jessnimm @ACCP @MDaware This is a great example of the sort of non-expert vaccine denialist target audience that contrarians like Prasad attract. https://t.co/lCLE7vH7AH https://t.co/rkjvjOB6rZ ht
@LeBobophobe @Julbert_5G @Neo_Shyro @myriampalomba Une formule ? Ouais alors non ça ne fonctionne pas avec "une formule" https://t.co/zjfXdqRP8v
RT @AtomsksSanakan: @Whitehorse1255 @TheDrJon @lasikeyecenter1 Harmful immune complexes were seen with SARS-CoV-2 infection, though, but no…
@Whitehorse1255 @TheDrJon @lasikeyecenter1 Harmful immune complexes were seen with SARS-CoV-2 infection, though, but not following vaccination. So SARS-CoV-2 vaccines working again. https://t.co/Gj4pCPLCox "Circulating multimeric immune complexes contri
@kusomitama @mph_for_doctors 試しに新型コロナワクチンの効果のコクランレビューに反論してみて下さいね。 https://t.co/BUOEK8tBxx
@BoussageonR @docdu16 @barriere_dr https://t.co/ifUpzvDYMd cherry picking? Parce que ceci dit le contraire
@DavidRotherton @NZFreeSpeech That's generally how medical standards regarding competence and best practice work with the Health and Disability Commissioner ruling based on the best peer-reviewed scientific evidence (meta-analyses and systematic reviews) w
@JR4_Truth @thereal_truther @Standup__Man @katwrappah @USMortality @JeromeAdamsMD Your denialist opinion on the topic is as evidence-free + worthless as your denialist opinions on topics like ivermectin, herd immunity, etc. https://t.co/H5q138vgDu https:
@ImmunoGangsta @Jikkyleaks @Debunk_the_Funk @DopplerEffect93 @SaltaoVladimir @ENirenberg @weldeiry @DravenS17 @gorskon There are way more vaccine denialists, conspiracists, pseudoskeptics, etc. who trust Wakefield on vaccines than trust me, competent docto
RT @Streitschuster: @aysiati @bast_i @SHomburg Gut, dass #Cochrane auch ein Review zu den Impfstoffen veröffentlicht hat. Dann sind wir uns…
RT @AtomsksSanakan: @jason_willz1 @TracyBethHoeg https://t.co/Ojx1gPeaQO Unsurprising to see a contrarian like Høeg resorting to the nirva…
@jason_willz1 @TracyBethHoeg https://t.co/Ojx1gPeaQO Unsurprising to see a contrarian like Høeg resorting to the nirvana fallacy, since it's an old vaccine denialist trope. 🤷♂️ https://t.co/tiqKNHvyN6 https://t.co/lCLE7vH7AH https://t.co/abzDsFm1Ab ht
@persephone28751 @gracefool @NZFreeSpeech LOL. I know what systematic reviews and meta-analyses are - often the very best scientific evidence we have. But in any case, no-one needs to take my word for it anyway, they can read the Dec 2022 Cochrane Library
@gracefool @persephone28751 @NZFreeSpeech No, that's not what I claimed. I provided all the references to the peer-reviewed articles including the meta-analyses and systematic reviews *that I cited*. More have been done since 2021 such as the 2022 Cochrane
@L2Feather @normanpie @VWNW @robinmonotti Sorry, but I'm not interested in evidence-free asinine conspiracy theories from paranoid non-experts. mRNA SARS-CoV-2 vaccines worked, and the mRNA technology justifiably won a Nobel prize. Deal with it. 🤷♂️ htt
@ancientastrokn3 @MadsOlesenDK @geoffmprice @ScottAdamsSays @CaulfieldTim It's no surprise non-expert vaccine denialists pat each other on the back. https://t.co/2VpGsRdxjC https://t.co/LsORVktsFE https://t.co/YBsQHUbxB0
@ancientastrokn3 @geoffmprice @MadsOlesenDK @ScottAdamsSays @CaulfieldTim Your incompetence is obvious https://t.co/2VpGsRdxjC https://t.co/Yu5Df4Q9if https://t.co/Pzxeib2Lpz
@ancientastrokn3 @geoffmprice @MadsOlesenDK @ScottAdamsSays @CaulfieldTim Again: Fact remains that RFK Jr. cherry-picked with no understanding of the broader literature or the relative quality of the studies in question. I get that why this is beyond your